HM Payson & Co. lessened its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 5.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 8,643 shares of the pharmacy operator’s stock after selling 527 shares during the period. HM Payson & Co.’s holdings in Walgreens Boots Alliance were worth $345,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of WBA. Norges Bank acquired a new stake in Walgreens Boots Alliance in the 4th quarter valued at approximately $312,858,000. Sprucegrove Investment Management Ltd. grew its stake in shares of Walgreens Boots Alliance by 189.1% in the fourth quarter. Sprucegrove Investment Management Ltd. now owns 2,667,850 shares of the pharmacy operator’s stock worth $106,394,000 after acquiring an additional 1,745,000 shares in the last quarter. Amundi Pioneer Asset Management Inc. grew its stake in shares of Walgreens Boots Alliance by 73.4% in the fourth quarter. Amundi Pioneer Asset Management Inc. now owns 3,092,329 shares of the pharmacy operator’s stock worth $123,278,000 after acquiring an additional 1,309,168 shares in the last quarter. American International Group Inc. grew its stake in shares of Walgreens Boots Alliance by 20.9% in the fourth quarter. American International Group Inc. now owns 4,973,586 shares of the pharmacy operator’s stock worth $198,347,000 after acquiring an additional 858,595 shares in the last quarter. Finally, Renaissance Technologies LLC grew its stake in shares of Walgreens Boots Alliance by 288.8% in the fourth quarter. Renaissance Technologies LLC now owns 924,200 shares of the pharmacy operator’s stock worth $36,857,000 after acquiring an additional 686,500 shares in the last quarter. Hedge funds and other institutional investors own 55.96% of the company’s stock.

Several equities analysts have commented on the stock. Royal Bank of Canada boosted their price target on shares of Walgreens Boots Alliance from $44.00 to $52.00 in a research note on Thursday, April 1st. Credit Suisse Group boosted their price target on shares of Walgreens Boots Alliance from $46.00 to $50.00 and gave the stock a “neutral” rating in a research note on Thursday, April 1st. Robert W. Baird upgraded shares of Walgreens Boots Alliance from a “neutral” rating to an “outperform” rating and boosted their price target for the stock from $41.00 to $55.00 in a research note on Monday, January 11th. Guggenheim upgraded shares of Walgreens Boots Alliance from a “neutral” rating to a “buy” rating and set a $55.00 target price for the company in a research note on Monday, January 11th. Finally, Morgan Stanley boosted their target price on shares of Walgreens Boots Alliance from $40.00 to $52.00 and gave the stock an “equal weight” rating in a research note on Tuesday, March 30th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $48.59.

Shares of NASDAQ:WBA opened at $55.58 on Thursday. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.32 and a current ratio of 0.67. The company has a 50-day simple moving average of $51.08 and a 200-day simple moving average of $43.77. Walgreens Boots Alliance, Inc. has a one year low of $33.36 and a one year high of $57.05. The stock has a market capitalization of $48.02 billion, a price-to-earnings ratio of 111.16, a PEG ratio of 1.52 and a beta of 0.44.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Tuesday, March 30th. The pharmacy operator reported $1.40 EPS for the quarter, beating the consensus estimate of $1.10 by $0.30. The business had revenue of $32.78 billion for the quarter, compared to analyst estimates of $36.16 billion. Walgreens Boots Alliance had a net margin of 0.33% and a return on equity of 18.33%. The company’s quarterly revenue was down 8.5% on a year-over-year basis. During the same period in the prior year, the business earned $1.52 earnings per share. As a group, research analysts forecast that Walgreens Boots Alliance, Inc. will post 4.84 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, March 12th. Stockholders of record on Friday, February 19th were given a $0.4675 dividend. The ex-dividend date of this dividend was Thursday, February 18th. This represents a $1.87 annualized dividend and a dividend yield of 3.36%. Walgreens Boots Alliance’s dividend payout ratio is presently 39.45%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Featured Article: Key terms to understand channel trading

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.